Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Candice C. Poon"'
Autor:
Susobhan Sarkar, Yibo Li, Reza Mirzaei, Khalil S. Rawji, Candice C. Poon, Jianxiong Wang, Mehul Kumar, Pinaki Bose, V. Wee Yong
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Myeloid cells that infiltrate into brain tumors are deactivated or exploited by the tumor cells. We previously demonstrated that compromised microglia, monocytes, and macrophages in malignant gliomas could be reactivated by amphotericin-B to contain
Externí odkaz:
https://doaj.org/article/ed69c87239664fc08c76aa7426a912dc
Autor:
John Kelly, Candice C. Poon
Publikováno v:
International Journal of Cancer. 140:1945-1954
Non-small cell lung cancer (NSCLC) is the number one cause of global mortality. Despite aggressive treatment, the prognosis is dismal. Patients with advanced NSCLC have a median survival of 4 months from the time of diagnosis. Fortunately, molecularl
Autor:
Susobhan Sarkar, Yibo Li, Reza Mirzaei, Khalil S. Rawji, Candice C. Poon, Jianxiong Wang, Mehul Kumar, Pinaki Bose, V. Wee Yong
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, Vol 11 (2020)
Myeloid cells that infiltrate into brain tumors are deactivated or exploited by the tumor cells. We previously demonstrated that compromised microglia, monocytes, and macrophages in malignant gliomas could be reactivated by amphotericin-B to contain
Autor:
Runze Yang, Paul M. K. Gordon, John Kelly, Katherine Liu, Candice C. Poon, Reza Mirzaei, V. Wee Yong, Susobhan Sarkar, Martha Hughes, Shiekh Tanveer Ahmad
Publikováno v:
Oncotarget
// Candice C. Poon 1 , Paul M.K. Gordon 2 , Katherine Liu 1 , Runze Yang 1 , Susobhan Sarkar 1 , Reza Mirzaei 1 , Shiekh Tanveer Ahmad 3 , Martha L. Hughes 1 , V. Wee Yong 1, * and John J.P. Kelly 1, * 1 Department of Clinical Neurosciences, Universi
Autor:
Reza Mirzaei, John Kelly, Pinaki Bose, Susobhan Sarkar, Walter Hader, Candice C. Poon, Khalil S. Rawji, Jeff F. Dunn, V. Wee Yong
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
We reported previously that microglia decreased the growth of human brain tumor-initiating cells (BTICs). Through microarray analyses of BTICs exposed in vitro to microglia, we found the induction of several genes ascribed to have roles in cell cycle
Publikováno v:
Journal of Visualized Experiments : JoVE
Automated slide scanning and segmentation of fluorescently-labeled tissues is the most efficient way to analyze whole slides or large tissue sections. Unfortunately, many researchers spend large amounts of time and resources developing and optimizing
Autor:
Carly Sabine Pontifex, Owen Stechishin, Brad Davis, Wei Wu, John Kelly, Michael D. Blough, Candice C. Poon, Yaoqing Shen, H. Artee Luchman
Publikováno v:
Neuro-Oncology. 18:350-360
Background: Glioblastoma (GBM) is a fatal cancer that has eluded major therapeutic advances. Failure to make progress may reflect the absence of a human GBM model that could be used to test compounds for anti-GBM activity. In this respect, the develo
Autor:
Tanveer Sheikh, John Kelly, Candice C. Poon, Runze Yang, Katherine Liu, V. Wee Yong, Susobhan Sarkar
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 45:S15-S16
Background: CNS innate immune cells, microglia and macrophages (MMs), are the largest component of the inflammatory infiltrate in glioblastoma (GBM). They initially participate in tumor surveillance, but are subverted by GBM. Immunotherapies have pro
Publikováno v:
Brain : a journal of neurology. 140(6)
Glioblastoma is the most common and most malignant primary adult human brain tumour. Diagnosis of glioblastoma carries a dismal prognosis. Treatment resistance and tumour recurrence are the result of both cancer cell proliferation and their interacti
Autor:
Candice C, Poon, John J, Kelly
Publikováno v:
International journal of cancer. 140(9)
Non-small cell lung cancer (NSCLC) is the number one cause of global mortality. Despite aggressive treatment, the prognosis is dismal. Patients with advanced NSCLC have a median survival of 4 months from the time of diagnosis. Fortunately, molecularl